Showing results (461-470 of 556) with videos related to

Sort By:
Pageof 56
Journal of Drugs in Dermatology : JDD|August 20, 2019
Efficacy of Dupilumab in Different Racial Subgroups of Adults With Moderate-to-Severe Atopic Dermatitis in Three Randomized, Placebo-Controlled Phase 3 TrialsAndrew F. Alexis, Marta Rendon, Jonathan I. Silverberg, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 19, 2023
Abrocitinib efficacy and safety in patients with moderate-to-severe atopic dermatitis: Results from phase 3 studies, including the long-term extension JADE EXTEND studyKristian Reich, Jonathan I Silverberg, Kim A Papp, et al.
American Journal of Clinical Dermatology|May 9, 2019
Infections in Dupilumab Clinical Trials in Atopic Dermatitis: A Comprehensive Pooled AnalysisLawrence F Eichenfield, Thomas Bieber, Lisa A Beck, et al.
Contact Dermatitis|April 12, 2021
Patch testing with sodium disulfite: North American Contact Dermatitis Group experience, 2017 to 2018Erin M Warshaw, Michele Buonomo, Joel G DeKoven, et al.
Contact Dermatitis|December 11, 2022
Prevalence and trend of allergen sensitization in patients with cheilitis referred for patch testing, North American Contact Dermatitis Group data, 2001-2018Jonathan I Silverberg, Manotri Chaubal, Erin M Warshaw, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|December 4, 2020
Positive Patch Test Reactions to Carba Mix and Thiuram Mix: The North American Contact Dermatitis Group Experience (1994-2016)Erin M Warshaw, Rachit Gupta, Jonathan I Silverberg, et al.
JAMA Dermatology|March 13, 2024
Expert Recommendations on Use of Topical Therapeutics for Vitiligo in Pediatric, Adolescent, and Young Adult PatientsYael Renert-Yuval, Khaled Ezzedine, Pearl Grimes, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|August 17, 2023
Patch Test Results Among Older Adults: A Retrospective Analysis of the North American Contact Dermatitis® Group Data (2009-2020)JiaDe Yu, Hadley Johnson, Joel G DeKoven, et al.
Immunotherapy|November 15, 2021
Comparing abrocitinib and dupilumab in the treatment of atopic dermatitis: a plain language summaryThomas Bieber, Eric L Simpson, Jonathan I Silverberg, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|January 14, 2022
Shoe Allergens: A Retrospective Analysis of Cross-sectional Data From the North American Contact Dermatitis Group, 2005-2018Amber Reck Atwater, Raina Bembry, Cynthia L Green, et al.
Pageof 56